BWC0977 formic is an antibacterial agent that inhibits bacterial DNA replication via inhibition of DNA gyrase and topoisomerase IV. BWC0977 formic exhibits a minimum inhibitory concentration (MIC90) of 0.03-2 µg/mL against MDR (Multi-Drug Resistant) Gram-negative bacteria[1].
References:
[1]. Shahul Hameed P, et al. BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections. Clinical Trial Nat Commun. 2024 Sep 18;15(1):8202.
BWC0977 formic 是一种抗菌剂,通过抑制 DNA 旋转酶 (DNA gyrase) 和拓扑异构酶 IV (topoisomerase IV) 来抑制细菌 DNA 复制。BWC0977 formic 对 MDR (多重耐药) 革兰氏阴性细菌的最低抑菌浓度 (MIC90) 为 0.03-2 µg/mL。
















